Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Tyligand Bioscience logo — Innovative small molecule therapeutics for cancer and autoim...

Tyligand Bioscience

Innovative small molecule therapeutics for cancer and autoimmune disease treatment.

Founded 2018 4 employees Series A Biotechnology, Health Care

General Information

Company Name Tyligand Bioscience
Founded Year 2018
Employees 4
Industries Biotechnology, Health Care
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Tyligand Bioscience. To contact Tyligand Bioscience, visit tyligand.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tyligand Bioscience compare?

A PDF of Tyligand Bioscience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tyligand Bioscience soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tyligand Bioscience

Tyligand Bioscience is a biotechnology company founded in 2018 with a focus on developing innovative small molecule therapeutics for cancer and autoimmune disease treatment. Their commitment to discovering and developing small molecule therapeutics has attracted significant investment, with the latest being a Series A investment on 08 July 2023. This round of funding was led by a consortium of investors including Calor Capital, Shengdi Investment, YF Capital, TaiKun Fund, Ming Bioventures, BOHE Angel Fund, CMS Capital. Tyligand Bioscience's unique approach and potential for impact in the biotechnology and healthcare industries have garnered notable attention from venture capital firms. Their mission to develop effective treatments for tumors and autoimmune disorders signifies a promising future in the field of healthcare innovation.

Business keywords: small molecule therapeutics, cancer treatment, autoimmune disease treatment, drug discovery, pharmaceuticals, medicine, oncology, immunology, patient health, tumor targeting, health outcomes

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 7
Calor Capital Ming Bioventures
Calor Capital, Ming Bioventures +5
08 Jul 2023
Seed Round Undisclosed 1
Med-Fine Capital
Med-Fine Capital
01 Jan 2020

Tyligand Bioscience Alternatives & Competitors

View All Alternatives
Tyligand Bioscience vs
Nimbus Therapeutics
Nimbus Therapeutics United States

We develop breakthrough medicines for patients through precision small molecule design.

103 employees
Biotechnology, Health Care
Tyligand Bioscience vs
Tempest Therapeutics
Tempest Therapeutics

Pioneering the future of cancer treatment with innovative small molecule therapeutics that enhance a...

Post-IPO Equity
11-50 employees
Biotechnology, Health Care
Tyligand Bioscience vs
IpiNovyx Bio
IpiNovyx Bio United States

We are a drug platform focused on treating autoimmune and inflammatory diseases.

Seed
6 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Tyligand Bioscience

Innovative small molecule therapeutics for cancer and autoimmune disease treatment.
Tyligand Bioscience was founded in 2018.
Tyligand Bioscience operates in Biotechnology and Health Care. Its work centres on small molecule therapeutics, cancer treatment, autoimmune disease treatment and drug discovery.
Tyligand Bioscience has approximately 4 employees.
Tyligand Bioscience has completed 2 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to Tyligand Bioscience include Nimbus Therapeutics, Tempest Therapeutics, IpiNovyx Bio, Aquinox Pharmaceuticals, 858 Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tyligand Bioscience and Nimbus Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tyligand Bioscience, https://bouncewatch.com/company/tyligand-bioscience, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout